Executive Summary
The 45 filings reveal an extraordinary concentration of CEO and CFO turnover on November 9, 2026, with at least 12 CEO transitions and 10 CFO/principal accounting officer changes announced or effective within a single week.
Succession-driven appointments (Sonoco, SiriusXM, Concentra, Century Communities, LKQ) dominate, but abrupt departures (Goodyear, Datavault AI, GeoVax) and interim arrangements (Genworth, Upstart, WaFd) signal governance stress at several small caps. Board refreshment is aggressive: at least 18 new director appointments and 15 retirements/resignations, with a clear pattern of adding finance, technology, and healthcare operating expertise ahead of strategic reviews, spin-offs, and mergers. Financial disclosures within the stream are sparse, but where present they show mixed trends: ArriVent's Phase 3 miss (HR 0.75, p=0.0654) and widening net loss ($133.5M vs $130.8M) contrast with BCSF's NII decline (10.9% YoY) and NAV erosion (4.3% YTD). Insider activity is limited but notable: Myriad Genetics granted large retention options to three NEOs (121k-147k shares) to ensure continuity, while Hims & Hers disclosed a $3.5M annual advisory deal with new director Andrew Huberman alongside a $5M podcast ad contract, raising related-party concerns. Capital allocation signals include Vistance's $16.50/share special distributions in 2026 and BCSF's $0.42 Q4 dividend, while WaFd's $1.65M continuity payment to its Chief Experience Officer underscores merger-related retention costs. Overall, the stream points to a late-2026 wave of leadership repositioning, with investors likely to reward clean successions and punish governance missteps.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from November 06, 2026.
Investment Signals (12)
- Goodyear Tire & Rubber (GT) (BEARISH)▲
Abrupt CEO departure (Mark Stewart out immediately) and interim CEO Roger Wood, while board conducts strategic review of business mix and footprint; CFO transition adds to uncertainty. Historically, abrupt CEO exits at large caps have preceded strategic pivots or breakups, but near-term execution risk is elevated
- Sonoco Products (SON) (BULLISH)▲
Orderly CEO succession: R. Howard Coker retires Dec 31, 2026, after 40 years; Ernest D. Haynes III (President, Global Consumer Packaging) takes over. Haynes led integration of largest acquisitions, suggesting continuity of strategy; 2025 sales of $7.5B provide scale
- SiriusXM (SIRI) (BULLISH)▲
Anjali Sud (Tubi CEO, SiriusXM director since March 2025) named CEO effective Jan 1, 2027, succeeding Jennifer Witz. Sud's digital/streaming background could accelerate subscriber growth initiatives; board cites return to revenue growth and near-record FCF
- Concentra Group (CON) (BULLISH)▲
CEO succession effective Nov 1: Matthew DiCanio (President/CFO) becomes CEO, William Newton becomes Executive Chairman, Tanner Newton CFO. New employment agreements and restricted stock grants (164,894 shares to DiCanio) align leadership with shareholders
- LKQ Corp (LKQ) ↓ (BULLISH)▲
Sal Abbate assumed President and CEO role on Nov 9, ahead of Dec 15 start, concluding interim Office of the CEO. Faster-than-expected transition reduces leadership uncertainty
- Myriad Genetics (MYGN)▲
Granted large retention stock options to CFO (121,379), COO (146,933), and CSO (92,632) with 3-year cliff vesting, explicitly to ensure leadership continuity amid operational efficiency initiatives. Retention awards signal board confidence but also potential concerns about departures [NEUTRAL/BULLISH]
- Bain Capital Specialty Finance (BCSF) (NEUTRAL)▲
Q3 NII of $27.7M ($0.43/share) and net income $0.26/share; EPS improved from $0.22 in Q2. However, NII declined YoY from $29.2M, and NAV fell to $16.49 from $17.23 at year-end 2025. Dividend of $0.42 maintained; non-accruals stable at 3.3%
- Vistance Networks (VISN)▲
CEO Chuck Treadway to step down Feb 1, 2027; board launches search. Company returned $16.50/share via special distributions in 2026, including $1.50 payable Nov 6, after debt repayment and preferred redemption. Focused network solutions business could attract strategic interest [NEUTRAL/BULLISH]
- Hims & Hers Health (HIMS) (MIXED)▲
Appointed Dr. Andrew Huberman to board (not independent) and signed $3.5M/year advisory deal plus $5M/year podcast ad contract with his co-owned Scicomm Media. Related-party nature may raise governance flags, but Huberman's large following could boost brand awareness
- KBR Inc (KBR) ↓ (BULLISH)▲
Announced eight-member board for Trinzic spin-off (expected Jan 4, 2027), with retired Lt. Gen. Wendy Masiello as Chair and CEO-designate Michael LaRouche as director. Spin-off with >$5B revenue and 20,000 employees could unlock value
- Century Communities (CCS) (BULLISH)▲
Promoted Jim Francescon to President effective Jan 1, 2027, as part of two-year succession plan; CEO Rob Francescon retains CEO role. Smooth succession planning reduces key-person risk
- Brady Corp (BRC) ↓ (BULLISH)▲
Elected Scott Robinson (former CFO, Donaldson Filtration Solutions) and Kenneth Spangler (former EVP/CIO, FedEx) to board, adding finance/M&A and technology expertise as Brady integrates Honeywell PSS acquisition. Board refreshment with relevant expertise
Risk Flags (10)
- Datavault AI (DVLT) [HIGH RISK]▼
CEO Nathaniel Bradley removed Nov 1, replaced by Brett Moyer; multiple executive changes (COO, CFO, Audit Chair). Risks include restatement of previously issued financials, Nasdaq minimum bid price non-compliance, potential reverse stock split, and litigation tied to removals. High governance instability
- GeoVax Labs (GOVX) [HIGH RISK]▼
Five directors resigned effective Oct 23, 2026; Tyler O'Brien named interim CEO and Chairman Nov 8. Prior termination of Mr. Dodd for 'Cause' may trigger severance (3x salary + bonus) and legal costs. Board exodus and management turnover signal deep distress
- ArriVent BioPharma (AVBP) (BEARISH)▼
Phase 3 FURVENT trial of firmonertinib missed primary PFS endpoint (median 11.0 vs 9.5 months, HR 0.75, p=0.0654). Net loss widened to $133.5M for nine months vs $130.8M; G&A jumped 61.7% to $28.3M. Cash runway to mid-2028, but pipeline setback is major
- Genworth Financial (GNW)▼
Controller Darren Woodell resigned Nov 6; CFO Jerome Upton named interim Principal Accounting Officer while also becoming President and CEO on Jan 1, 2027. Concentration of roles during transition raises oversight risk [NEUTRAL/BEARISH]
- Upstart Holdings (UPST) (NEUTRAL)▼
Chief Accounting Officer Natalia Mirgorodskaya resigned effective Nov 30; CFO Andrea Blankmeyer takes on interim PAO role without additional compensation. Departure not due to disagreement, but turnover in accounting leadership bears watching
- WaFd Inc (WAFD)↓ (NEUTRAL)▼
Chief Experience Officer Cathy Cooper received $1.65M continuity payment tied to EverBank merger closing, waiving 'good reason' triggers. Retention cost and potential for further executive departures during merger integration
- Pangaea Logistics (PANL)▼
Chairman Richard du Moulin retiring Dec 31, 2026; no successor named. Leadership vacuum at board level could complicate strategic direction [NEUTRAL/BEARISH]
- Sypris Solutions (SYPR) (NEUTRAL)▼
VP of Administration Curtis Petrie on medical leave effective Nov 3, duration undetermined. Key person risk at small cap
- Bain Capital Specialty Finance (BCSF) (BEARISH)▼
NAV per share declined 4.3% from $17.23 (Dec 31, 2025) to $16.49 (Sept 30, 2026); total investment income fell 10.9% YoY to $59.9M. NII coverage of dividend may be pressured if trend continues
- Hims & Hers Health (HIMS) [RISK]▼
Related-party transactions with new director Andrew Huberman (advisory and advertising deals totaling up to $8.5M annually) may draw governance scrutiny and conflict-of-interest concerns
Opportunities (10)
- SiriusXM (SIRI) (OPPORTUNITY)◆
New CEO Anjali Sud brings digital streaming expertise from Tubi and Vimeo; could accelerate subscriber growth and digital transformation. Stock may re-rate on fresh strategic vision
- KBR Inc (KBR)↓ (OPPORTUNITY)◆
Trinzic spin-off expected Jan 4, 2027, with >$5B revenue and 20,000 employees; board includes retired Lt. Gen. Wendy Masiello and CEO-designate Michael LaRouche. Spin-offs often unlock shareholder value
- Concentra Group (CON) (OPPORTUNITY)◆
New CEO Matthew DiCanio (former CFO) and new CFO Tanner Newton; restricted stock grants align interests. Operational continuity and potential margin improvement
- LKQ Corp (LKQ)↓ (OPPORTUNITY)◆
Sal Abbate started as CEO earlier than expected, ending interim period. New leadership may accelerate strategic initiatives
- Vistance Networks (VISN) (OPPORTUNITY)◆
After returning $16.50/share in 2026 and repaying debt, company is a focused network solutions business. CEO search could bring fresh leadership; potential acquisition target
- Sonoco Products (SON) (OPPORTUNITY)◆
CEO-elect Ernest Haynes has deep operational experience and led integration of largest acquisitions. Smooth transition could drive continued growth
- Myriad Genetics (MYGN) (OPPORTUNITY)◆
Retention options for key executives (CFO, COO, CSO) with 3-year cliff vesting signal board confidence in turnaround; if operational efficiencies improve, stock could rebound
- Century Communities (CCS) (OPPORTUNITY)◆
Jim Francescon promoted to President as part of succession plan; his private equity and investment banking background may bring fresh perspective to homebuilding strategy
- Brady Corp (BRC)↓ (OPPORTUNITY)◆
New directors with finance/M&A and technology expertise (Scott Robinson, Kenneth Spangler) as company integrates Honeywell PSS acquisition; could drive synergies and digital transformation
- Armada Hoffler Properties (AHH) (OPPORTUNITY)◆
Added David Hirsh (16 years at Blackstone, >$30B transactions) to board; his real estate investment expertise could help optimize portfolio and capital allocation
Sector Themes (6)
- CEO Turnover Wave (THEME)◆
12+ CEO transitions announced or effective in a single week (Goodyear, Sonoco, SiriusXM, Concentra, LKQ, Vistance, Datavault, GeoVax, Century Communities, etc.), spanning industrials, consumer, healthcare, and tech. This suggests a broad-based leadership reset as companies position for 2027 amid economic uncertainty
- Board Refreshment and Expertise Injection (THEME)◆
At least 18 new director appointments and 15 retirements/resignations, with a clear trend toward adding finance, technology, and healthcare operating experience (e.g., Brady, FedEx, Stryker, UnitedHealth, Newell). Boards are being reshaped to oversee strategic reviews, M&A integration, and digital transformation
- M&A and Spin-Off Activity Driving Governance Changes (THEME)◆
KBR's Trinzic spin-off board announcement, WaFd's merger-related retention payment, and Datavault's restructuring highlight how transactions are catalysts for leadership changes. Expect more board and executive shifts as companies separate or integrate
- Small-Cap Governance Instability (THEME)◆
Datavault AI, GeoVax Labs, and Adial Pharmaceuticals (Azora) all executed wholesale board/management overhauls, often with abrupt departures and interim appointments. These situations carry higher risk but also potential for turnaround if new leadership executes
- Retention and Compensation Pressures (THEME)◆
Myriad Genetics' large retention options, WaFd's $1.65M continuity payment, and Hims & Hers' lucrative advisory deals show boards using financial incentives to secure key talent amid turnover. This may weigh on near-term earnings but signals commitment to strategy
- Financial Performance Divergence (THEME)◆
Where financials were disclosed, results were mixed: ArriVent's trial miss and widening loss contrast with BCSF's stable NII and dividend. Most governance filings lacked financial updates, but the few available suggest a challenging operating environment
Watch List (8)
- Datavault AI (DVLT) (WATCH)👁
Q3 2026 results to be reported on a date to be announced; watch for details on restatement, Nasdaq compliance, and potential reverse split. High risk/reward
- GeoVax Labs (GOVX) (WATCH)👁
Interim CEO Tyler O'Brien's strategic review; potential litigation from former CEO Dodd's termination. Monitor for severance payout and new direction
- Goodyear Tire & Rubber (GT) (WATCH)👁
CEO search and strategic review outcomes; interim CEO Roger Wood's comments on business mix and footprint optimization. Earnings call likely to address transition
- SiriusXM (SIRI) (WATCH)👁
Anjali Sud's transition to CEO effective Jan 1, 2027; watch for strategic plan and any guidance updates on subscriber trends
- KBR Inc (KBR)↓ (WATCH)👁
Trinzic spin-off launch expected Jan 4, 2027; final board approval and separation details. Potential value unlock
- Lisata Therapeutics (LSTA) (WATCH)👁
Reconvened annual meeting on Nov 30, 2026 to vote on Proposal No. 3 (Series C conversion/change of control). Outcome could significantly impact share count and control
- Bain Capital Specialty Finance (BCSF) (WATCH)👁
Q4 2026 dividend of $0.42 declared; watch for NAV stability and NII coverage in upcoming quarters
- Hims & Hers Health (HIMS) (WATCH)👁
Related-party transactions with Dr. Andrew Huberman may draw scrutiny; monitor for governance concerns and potential shareholder backlash
Filing Analyses
(45)
09-11-2026
Ocular Therapeutix elected Riad Sherif, M.D. (age 58, CEO of Oculis Holding AG) to its Board as a Class I director effective November 6, 2026, serving until the 2027 annual meeting. Concurrently, Seung Suh Hong, Ph.D. notified the Company of his resignation from the Board effective December 31, 2026, which the Company stated was not the result of any disagreement with the Board or management. Dr. Sherif received a standard non-employee director package: an option for 88,000 shares at $6.60 per share and a restricted stock unit award for 28,000 shares, each vesting annually over three years.
- · Dr. Sherif designated as Class I director, term ending at the 2027 annual meeting of stockholders
- · Dr. Hong's resignation effective December 31, 2026
- · No arrangements or understandings between Dr. Sherif and any other person regarding his election; no Item 404(a) related-party transactions disclosed
- · Dr. Sherif has served as CEO and board member of Oculis Holding AG since December 2017
- · Dr. Sherif has served on the Board of Revenio Group Oyj since March 2022
- · Dr. Sherif holds an M.D. from the Medical School of Algiers, an MBA from IMD Business School, and a Specialized Master's Degree in Medical Management from ESCP Business School
- · Dr. Sherif entered into the Company's standard Indemnification Agreement (previously filed as Exhibit 10.12 to Form S-1, File No. 333-196932, filed June 20, 2014)
- · Director compensation details referenced in proxy statement filed April 30, 2026
09-11-2026
Goodyear announced an abrupt CEO transition: Mark Stewart stepped down as CEO, president and board member effective immediately, with director Roger Wood (board member since 2023, former co-CEO of Tenneco) appointed interim CEO while the board launches a search with a leading executive search firm. The board's special committee and Enterprise Transformation Office continue a strategic review evaluating business mix, footprint optimization and efficiency initiatives, but the company declined to commit to further disclosure. Separately, Jerome Rouquet (current Visteon CFO) will become EVP and CFO effective December 1, 2026, succeeding interim CFO Scott Deakin.
- · Mark Stewart's departure as CEO, president and director was effective immediately
- · Roger Wood has served on Goodyear's board since 2023 and brings more than three decades of automotive and manufacturing leadership experience
- · Wood is stepping down as chair of the board's human capital & compensation committee
- · Jerome Rouquet's CFO appointment was announced October 27, 2026, effective December 1, 2026; he previously held senior finance roles at Tenneco and Federal-Mogul
- · The special committee was formed earlier this year; the company said it does not intend to provide further updates unless and until the board determines disclosure is appropriate or required
- · Goodyear operates two Innovation Centers in Akron, Ohio and Colmar-Berg, Luxembourg
09-11-2026
Azora Therapeutics (formerly Adial Pharmaceuticals) overhauled its board effective November 3, 2026, appointing three independent directors — Aida Habtezion, M.D., Paul Hastings and Thomas Soloway — while four directors (J. Kermit Anderson, Cary Claiborne, Robertson Gilliland, Kevin Schuyler) resigned without disagreement, and Matthew Davidson was named Board chair with the board reduced to five members. Separately, 9,924.260 shares of Series A Preferred Stock automatically converted into 9,924,260 shares of Common Stock on November 2, 2026, leaving 3,006.341 preferred shares outstanding and 14,243,129 common shares outstanding as of November 4, 2026. No director compensation arrangements have been finalized and no equity awards were granted to the new directors.
- · Dr. Habtezion's term expires at the 2028 Annual Meeting; Hastings and Soloway terms expire at the 2029 Annual Meeting
- · Audit committee members meet Rule 10A-3 and Nasdaq heightened independence requirements
- · Each new director entered into the Company's standard indemnification agreement (Exhibit 10.7 to FY2025 10-K filed March 5, 2026)
- · Stockholders approved the preferred conversion at the reconvened 2026 Annual Meeting on October 28, 2026 under Nasdaq Rules 5635(a) and 5635(b)
- · The Series A Preferred Stock was issued to former Azora Therapeutics stockholders in connection with the Company's acquisition of that company on June 11, 2026
- · Company changed its name from Adial Pharmaceuticals, Inc. and relocated its principal offices to 16501 Ventura Blvd, Suite 400, Encino, CA 91436
- · No arrangements or understandings underlie the new director appointments, and no related-party transactions under Item 404(a) were disclosed
09-11-2026
Sonoco Products Company announced that CEO R. Howard Coker will retire effective December 31, 2026, after more than 40 years with the company. The Board has elected Ernest D. Haynes III, currently President, Global Consumer Packaging, to succeed him as President, CEO and director. The company, with 2025 sales of $7.5 billion from continuing operations and approximately 22,000 employees, frames the transition as part of orderly succession planning, though the release contains no quantitative performance data for the current or prior periods.
- · Coker's retirement is effective December 31, 2026, and he remains in role until then, so Haynes will be CEO-elect during the interim
- · Haynes has been with Sonoco since 1997 and assumed his current role as President, Global Consumer Packaging in August 2026
- · Haynes led the metal packaging and rigid paper packaging businesses through integration of the company's largest acquisitions
- · Coker and Haynes will present together with CFO Paul Joachimczyk at R.W. Baird's 2026 Global Industrial Conference on November 10, 2026 at 7:20 a.m. Central Time, with a replay on the investor relations site
- · The forward-looking statements flag risks tied to the leadership transition, including retention of key personnel and execution of portfolio simplification and organizational streamlining
09-11-2026
Five Star Bancorp appointed banking veteran Christopher D. Myers, former President and CEO of CVB Financial Corp., to the boards of the Company and Five Star Bank, effective via press release dated November 4, 2026. The appointment supports Five Star's Southern California expansion, following the addition of five banking professionals and new Calabasas and Newport Beach offices. No financial results or period-over-period metrics were disclosed in this governance announcement.
- · Myers served as President and CEO of CVB Financial Corp. for nearly 15 years until his 2020 retirement
- · Under Myers, Forbes named Citizens Business Bank 'Best Bank in America' in 2016 and 'Best Bank in California' in 2019
- · Myers previously served as Chairman and CEO of Mellon First Business Bank
- · Myers currently serves on the board of CoinShares (Nasdaq: CSHR) and the UCLA Anderson Fink Center for Finance and Investments
- · Myers' regional expertise spans Ventura, Los Angeles, Orange, Riverside, and San Bernardino counties
- · Five Star operates ten branches in California and is headquartered in Rancho Cordova
09-11-2026
LASE Corp. (NASDAQ: LASE) appointed CFO Tim Peterman and Sanjay Adhav, President of Quantum Technology, Inc., to its Board of Directors effective November 3, 2026, filling two existing vacancies. The company framed the additions as strengthening governance and SEC compliance (Peterman) and deepening directed-energy/quantum component expertise (Adhav). No financial figures, revenue, or period-over-period metrics were disclosed in this filing.
- · Appointments effective November 3, 2026; press release dated November 9, 2026
- · Tim Peterman served as CEO of iMedia Brands from 2019 to 2023 and as Director from 2020 to 2023, after serving as CFO from 2015 to 2018
- · Peterman began his career at KPMG in Chicago and holds a BS in accounting from the University of Kentucky; he is a CPA with an inactive license
- · Sanjay Adhav has served as President of Quantum Technology, Inc. since 2013
- · Adhav holds a BS in Electrical Engineering from the University of Toronto and has co-authored research in Applied Optics and Applied Physics Letters
- · Executive Chairman Dmitri Nikitin noted the Board historically had limited experience in Nasdaq governance, SEC compliance, capital markets and M&A
- · Filing includes Items 5.02 (officer/director change), 7.01 (Reg FD) and 9.01 (financial statements/exhibits)
- · No financial results, revenue, or guidance figures were provided
09-11-2026
Datavault AI overhauled its leadership effective immediately: Brett Moyer was appointed CEO and President, succeeding Nathaniel Bradley, who was removed as CEO and President on November 1, 2026 but remains a board member. Kimberly Briskey was named Chair of the Board, Sri Peruvemba Vice Chair, Teri Gallo COO, Stanley Mbugua CFO (succeeding Moyer), and Christopher R. Hardt Chair of the Audit Committee; former executive Sonia Choi is no longer with the company. The filing disclosed no financial figures, but the release flags risks including a restatement of previously issued financial statements, Nasdaq minimum bid price compliance and potential reverse stock split, and possible litigation tied to the executive removals; Q3 2026 results will be reported on a date to be announced.
- · Nathaniel Bradley was removed as CEO and President on November 1, 2026, and remains a member of the Board
- · Sonia Choi, formerly an executive, is no longer with the Company and is not authorized to act on its behalf
- · Brett Moyer served as CFO from January 2025 until his CEO appointment and was Chairman of the Board until November 6, 2026
- · Moyer was a founding member of WiSA Technologies and served as its President and CEO from August 2010 through December 2024
- · Teri Gallo has served as CEO of NYIAX since 2024, leading two acquisitions and its merger with Datavault
- · Stanley Mbugua was previously Chief Accounting Officer at Presto Automation (March 2023–August 2024), Skillz (September 2021–March 2023) and Rimini Street (September 2017–June 2021)
- · Christopher R. Hardt is a CPA and former PwC partner who led Consumer Markets SEC Services in PwC's National Office
- · Forward-looking risk disclosures cite restatement of previously issued financial statements, Nasdaq minimum bid price compliance, timing/effect of any reverse stock split, and potential litigation over officer removals
- · Q3 2026 results timing and any conference call/webcast details will be announced separately
09-11-2026
Vistance Networks (NASDAQ: VISN) announced CEO Chuck Treadway will step down as President, CEO and board member effective February 1, 2027, with the Board launching a CEO search aided by a leading executive search firm. Treadway, CEO since October 2020, oversaw divestitures, full repayment of outstanding debt and redemption of all preferred equity; including a $1.50 per share special cash distribution payable November 6, 2026, the company will have returned $16.50 per share to shareholders via special distributions in 2026. The company now operates as a focused network solutions business through Aurora Networks and separately reported Q3 2026 results the same day.
- · Treadway has served as President and CEO since October 2020
- · Departure effective February 1, 2027
- · Board retained a leading executive search firm
- · Company repaid all outstanding debt and redeemed all outstanding preferred equity
- · Q3 2026 results released separately; conference call scheduled 8:30 am ET
- · Ticker NASDAQ: VISN; headquarters Richardson, TX
09-11-2026
National Healthcare Properties, Inc. (Nasdaq: NHP) expanded its Board from six to eight directors and, effective November 9, 2026, elected Jeffrey S. Olson and Craig S. Smith as independent directors to fill the resulting vacancies, with both serving until the 2027 annual meeting. Olson, Chairman and CEO of Urban Edge Properties (NYSE: UE) and former CEO of Equity One, joins the Compensation and Corporate Governance Committee, while Smith, CEO of Aimbridge Hospitality since 2024 and a former Marriott International Group President, joins the Audit Committee. Both were deemed independent under Nasdaq standards and will receive standard non-employee director compensation plus indemnification agreements; no family relationships or Item 404(a) transactions were disclosed.
- · Board increased from six to eight directors on November 6, 2026, upon recommendation of the Compensation and Corporate Governance Committee
- · Olson appointed to the Compensation and Corporate Governance Committee; Smith appointed to the Audit Committee
- · Smith satisfies additional independence requirements for audit committee members under Exchange Act Rule 10A-3
- · Both directors will receive non-employee director compensation per the 'Compensation of Directors' section of the Schedule 14A proxy filed March 31, 2026
- · Both will enter into the Company's standard indemnification agreement with expense advancement under Maryland law
- · No family relationships, side arrangements, or Item 404(a) related-party transactions disclosed for either director
- · Filing signed by Andrew T. Babin, Chief Financial Officer and Treasurer, dated November 9, 2026
- · Exhibit 104 cover page XBRL tags embedded within Inline XBRL
09-11-2026
WaFd, Inc. (NASDAQ: WAFD) disclosed a letter agreement dated November 2, 2026 with Chief Experience Officer Cathy E. Cooper providing a $1.65 Million lump-sum continuity payment, payable within 60 days after closing of the pending merger with EverBank Financial Corp, conditioned on her employment through closing. In exchange, she will waive certain 'good reason' triggers under her change-of-control agreement arising from her transition to a new role with the surviving corporation. The filing is primarily an executive compensation and retention disclosure tied to the previously announced EverBank merger signed September 6, 2026.
- · Ms. Cooper waives 'good reason' triggers under her existing change-of-control agreement, effective at closing, to the extent arising from her transition to a role with the Surviving Corporation.
- · WaFd filed a definitive proxy statement on Schedule 14A on November 4, 2026, first mailed to shareholders on or about that date.
- · Merger structure: EverBank merges into WaFd, with WaFd as the surviving corporation.
09-11-2026
Brady Corporation elected Scott J. Robinson (former CFO of Donaldson Filtration Solutions) and Kenneth J. Spangler (former EVP/CIO at FedEx) to its Board of Directors effective November 9, 2026, while Board member Pat Allender retires after 19 years of service. The appointments add finance/M&A and enterprise technology expertise as Brady integrates its recent Honeywell PSS acquisition. No financial results or guidance were disclosed in the filing.
- · Robinson served as CFO of Donaldson Filtration Solutions from 2015 until retirement in 2024
- · Spangler was EVP, IT and CIO, Global Operating Technologies at FedEx from 2018 until retirement in 2024
- · Both new directors' appointments are effective November 9, 2026
- · Robinson holds a CPA and a BS in Accounting from St. Cloud State University; Spangler holds a BS in Information Science from University of Pittsburgh
- · Brady trades on NYSE under symbol BRC and is headquartered in Milwaukee, Wisconsin
09-11-2026
Newell Brands announced that William 'Bill' Newlands, former President and CEO of Constellation Brands, has been elected to its Board of Directors effective January 1, 2027, expanding the Board from eight to nine members. The appointment brings consumer brand-building and public company governance experience, and no financial results or guidance were disclosed in this release.
- · Mr. Newlands currently serves as non-executive Chairman of Hormel Foods Corporation and as a Director of Keurig Dr Pepper, which may bear on board independence and overboarding considerations.
- · Mr. Newlands previously held progressive leadership roles at Constellation Brands: EVP and Chief Growth Officer (joined 2015), President Wine & Spirits (2016), COO (2017), President (2018), then CEO (2019).
- · Mr. Newlands holds an MBA from Harvard Business School and a Bachelor of Science from the Wharton School of the University of Pennsylvania.
- · The press release does not disclose committee assignments, compensation, or any stated reason for Mr. Newlands' April 2026 departure from Constellation Brands.
09-11-2026
Sypris Solutions disclosed in an 8-K that Vice President of Administration Curtis S. Petrie began a medical leave of absence effective November 3, 2026, with the duration of the leave not yet determined. The filing contains no financial data, no revenue or earnings figures, and no compensatory arrangements tied to the leave. The disclosure is a routine officer-status update with limited near-term financial impact.
- · Medical leave effective date: November 3, 2026
- · 8-K filing date: November 9, 2026
- · Duration of the leave has not yet been determined
- · Filing signed by Rebecca R. Eckert, Vice President, Chief Accounting Officer & Controller
- · No interim replacement for Petrie was disclosed in the filing
09-11-2026
John Hancock Comvest Private Income Fund disclosed that CFO Cecilio Rodriguez will resign effective close of business November 16, 2026, tied to his retirement from Manulife | Comvest Credit Partners effective December 31, 2026; the Fund stated the resignation is not due to any disagreement over operations, policies, practices, or accounting matters. The Board appointed Fernando Silva, currently Chief Accounting Officer and Treasurer, as CFO effective November 17, 2026, consolidating the CFO, CAO, and Treasurer roles in one person. No compensatory arrangements, related-party transactions, or financial terms were disclosed, making this a routine, non-financial governance update.
- · Rodriguez's resignation takes effect at the close of business on November 16, 2026, one day before Silva's appointment becomes effective on November 17, 2026.
- · Silva has served as the Fund's Chief Accounting Officer and Treasurer since May 2026.
- · Silva has been CFO (Principal Financial Officer and Principal Accounting Officer) of various trusts within the John Hancock Fund Complex since 2024 and Vice President, Fund Administration at John Hancock Investment Management since 2024.
- · Silva has been Vice President of John Hancock Life & Health Insurance Company, John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York since 2021 (including prior positions), and Assistant Treasurer of John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC since 2020.
- · Silva previously served as Assistant Vice President, Treasury & Portfolio Services at John Hancock Investment Management from May 2020 to June 2024 and Director, Financial Reporting from February 2016 to May 2020.
- · Silva holds a B.A. in Hispanic Studies from Boston College and an M.S. in Accounting and M.B.A. from Northeastern University.
- · No arrangement or understanding exists between Silva and any other person regarding his appointment, and no Item 404(a) related-party transactions have occurred since the start of the last fiscal year.
- · The Fund is a Delaware entity (Commission File No. 814-01669, I.R.S. EIN 93-4109571) headquartered at 360 S. Rosemary Avenue, Suite 1700, West Palm Beach, FL 33401, and is an emerging growth company with no securities registered under Section 12(b).
09-11-2026
Mueller Industries, Inc. (NYSE: MLI) declared a regular quarterly cash dividend of 17.5 cents per share, payable December 18, 2026 to shareholders of record on December 4, 2026. The 8-K was filed under Items 5.02, 8.01 and 9.01, but the attached release (EX-99.1) covers only the dividend declaration and contains no officer or director departure/election details, so the preliminary 'Officer Change' classification is not supported by the disclosed content.
- · Dividend payable date: December 18, 2026
- · Shareholders of record date: December 4, 2026
- · Filing lists Items 5.02, 8.01 and 9.01, but the attached EX-99.1 release addresses only the dividend declaration
- · Company describes holdings spanning air, water, oil and gas distribution, climate comfort, food preservation, electrical transmission, medical, aerospace and automotive markets across North America, Europe, Asia and the Middle East
09-11-2026
ArriVent BioPharma reported Q3 2026 results with cash and investments of $393.2 million expected to fund operations to mid-2028. The company disclosed that its Phase 3 FURVENT trial of firmonertinib did not meet its primary PFS endpoint (median PFS 11.0 vs 9.5 months, HR 0.75; p=0.0654), though confirmed ORR was 60% vs 33%. Net loss widened to $133.5 million for the nine months versus $130.8 million a year earlier, while R&D expenses declined to $118.9 million from $121.2 million and G&A rose to $28.3 million from $17.5 million.
- · FURVENT missed primary PFS endpoint by BICR: HR 0.75, p=0.0654 (not statistically significant)
- · Firmonertinib 240 mg median PFS 11.0 months vs 9.5 months for chemotherapy in FURVENT
- · G&A expenses rose 61.7% to $28.3M from $17.5M for the nine months
- · Net loss widened 2.1% to $133.5M from $130.8M for the nine months
- · R&D expenses declined 1.9% to $118.9M from $121.2M
- · Net cash used in operations decreased to $122.2M from $129.9M
- · Accumulated deficit grew to $538.167M from $404.641M at December 31, 2025
- · Common shares outstanding increased to 51,212,170 from 42,452,251
- · Planned firmonertinib update in Q1 2027; ARR-217 Phase 1b dose optimization data expected H1 2027, combination data H2 2027
- · Dr. Stuart Lutzker, co-founder and President of R&D, announced retirement
- · ARR-217 Phase 1 data presented at ESMO 2026 as late-breaking rapid oral presentation
09-11-2026
Myriad Genetics' Compensation and Human Capital Committee approved one-time retention stock option awards on November 6, 2026 for three named executive officers — CFO Benjamin R. Wheeler (121,379 shares), COO Mark S. Verratti (146,933 shares) and CSO Dale Muzzey (92,632 shares) — explicitly to promote leadership continuity as the company executes initiatives to improve operational efficiencies and financial performance. The options carry a 10-year term and vest fully on the third anniversary of the grant date, subject to continued service, with exercise prices set at the grant-date closing price. The filing discloses no financial results or performance metrics, and the retention framing implies leadership-retention concerns rather than any reported operational improvement.
- · Awards were granted under the 2026 Employee, Director and Consultant Equity Incentive Plan
- · Exercise price equals the closing price of common stock on the grant date
- · Vesting is cliff-style at the third anniversary, not graded over time
- · Upon termination for cause, options terminate immediately whether or not vested
- · Vested options generally remain exercisable for three months following non-cause termination
- · Awards are subject to each recipient's Severance and Change in Control Agreement
- · Form of Stock Option Agreement filed as Exhibit 10.1
- · Company incorporated in Delaware; principal offices in Salt Lake City, Utah; IRS EIN 87-0494517; Commission File Number 0-26642
09-11-2026
AH Realty Trust (NYSE: AHRT) announced that founder Daniel Hoffler retired from its Board of Directors effective November 6, 2026, and the Board appointed David Hirsh as a new independent director on the same date. The changes are part of an ongoing Board refreshment process; Hirsh brings over three decades of real estate investing experience, including 16 years at Blackstone and more than $30 billion in career transactions. No financial results or guidance were disclosed, and the filing contains no performance metrics to compare period-over-period.
- · Board changes effective November 6, 2026; announcement dated November 9, 2026
- · David Hirsh retired in 2018 after 16 years at Blackstone's Real Estate Asset Management Group
- · Hirsh oversaw Equity Office Properties, IndCor Industrial Properties and the LXR Hotels and Resorts portfolio at Blackstone
- · Hirsh currently serves on the boards of Seaport Entertainment Group Inc. (NYSE: SEG) and Comstock Holding Companies, Inc. (Nasdaq: CHCI)
- · Hirsh holds a B.B.A. from Pace University and an M.S. from New York University
- · AH Realty Trust describes itself as a REIT with over four decades of experience owning retail and mixed-use office assets primarily in the Mid-Atlantic and Southeastern United States
- · No financial results, guidance, or period-over-period metrics were disclosed in this filing
09-11-2026
FedEx Corp. (NYSE: FDX) announced the election of Katherine M. Boyle, General Partner at Andreessen Horowitz and co-founder of its American Dynamism practice, to its Board of Directors effective Nov. 9, 2026. The board now consists of 12 directors, nine of whom are independent, and Boyle will serve on the Cyber and Technology Oversight Committee and the Governance, Safety, and Public Policy Committee. The filing contains no financial results or period-over-period metrics; it is a governance update only.
- · Boyle co-founded Andreessen Horowitz's American Dynamism practice in 2021, which invests in aerospace, defense, advanced manufacturing, logistics, energy, infrastructure, and government technology
- · Boyle previously spent five years at General Catalyst, rising from associate to principal to partner
- · Boyle began her career as a general assignment reporter at the Washington Post and serves on the board of the Mercatus Center
- · FedEx targets carbon-neutral operations by 2040
- · Forward-looking risks cited include global trade volatility and execution of the global transformation program, Network 2.0, and Tricolor
09-11-2026
Stryker (NYSE:SYK) announced on November 9, 2026 that its board has nominated Jim Davis, Chairman, CEO and President of Quest Diagnostics, for election to the board effective January 1, 2027. The filing is a routine governance update with no financial figures, guidance changes, or period-over-period metrics disclosed; CEO Kevin Lobo cited Davis's healthcare, operational and medical technology experience as a strong addition. No negative or flat performance data is present because the release contains no operating or financial results.
- · Board nomination becomes effective January 1, 2027
- · Jim Davis previously served as CEO of InSightec, Inc., a global medical device company
- · Davis spent two decades in senior management roles across GE's healthcare and aviation businesses, including five years leading GE's MRI business
- · Davis previously led strategic and operating initiatives for McKinsey & Company clients
- · Davis holds a master's degree in management from MIT Sloan, a master's degree in science from MIT, and a bachelor's degree in aeronautical engineering from the University of Michigan
- · Stryker describes itself as offering products and services in MedSurg, Neurotechnology and Orthopaedics
- · Investor and media contacts listed at 269-385-2600
09-11-2026
Immuneering Corporation appointed Grant C. Bogle, MBA, to its Board of Directors as a Class III Director effective November 9, 2026. Bogle will receive standard non-employee director compensation and has entered into the Company's standard indemnification agreement, but has not been appointed to any Board committee at this time. The filing discloses no arrangement or understanding underlying his election and contains no financial or operating metrics.
- · Bogle was appointed as a Class III Director, a classified board seat
- · Bogle has not been appointed to any Board committee at this time
- · No arrangement or understanding existed pursuant to which Bogle was elected
- · Bogle entered into the Company's standard indemnification agreement for directors and officers
- · Compensation follows the Company's existing non-employee director arrangements
- · Company is an emerging growth company and is incorporated in Delaware (Commission File Number 001-40675; IRS EIN 26-1976972)
- · Principal executive offices: 245 Main St., Second Floor, Cambridge, MA 02142
09-11-2026
Pathward Financial disclosed that former President Anthony Sharett resigned and ceased employment effective October 23, 2026. On November 3, 2026, the Compensation Committee approved a $340,923 cash payment to Sharett as his Fiscal 2026 annual incentive award, which he was otherwise ineligible to receive due to his departure, subject to his execution of an acknowledgement. The payment reflects full-year employment during the Fiscal 2026 performance period and includes an individual discretionary component.
- · Sharett's resignation and cessation of employment were effective October 23, 2026
- · The $340,923 payment was approved by the Compensation Committee of the Boards of the Company and Pathward on November 3, 2026
- · Payment was based on achievement of predetermined Fiscal 2026 performance measures plus an individual discretionary component
- · Receipt of the payment is conditioned on Sharett executing an acknowledgement, which the Company intends to file as an exhibit to its Form 10-K for fiscal year ended September 30, 2026
- · The 8-K was signed by Gregory A. Sigrist, EVP and CFO, and filed November 9, 2026
09-11-2026
Genworth Financial accepted the resignation of VP and Controller Darren W. Woodell (Principal Accounting Officer) effective November 6, 2026, and appointed EVP and CFO Jerome T. Upton as interim Principal Accounting Officer. Upton's compensation is unchanged, and he will also become President and CEO on January 1, 2027, following Thomas J. McInerney's retirement, concentrating multiple senior roles in one executive during the transition.
- · Woodell's intention to resign was previously announced October 13, 2026; resignation accepted November 6, 2026
- · Upton serves as interim Principal Accounting Officer until a permanent successor is appointed
- · Upton's compensatory arrangements will not change as a result of the interim appointment
- · Upton's CEO appointment effective January 1, 2027 was previously announced October 30, 2026
- · No arrangements or understandings between Upton and any other person regarding the appointment; no family relationships with directors or officers
- · Item 5.02(c)(2) information on Upton is incorporated by reference to the Form 10-K filed February 27, 2026 (Item 10)
- · 8-K signed by Michael J. McCullough, SVP and Corporate Secretary, dated November 9, 2026
09-11-2026
MVB Financial Corp entered into Restated Executive Employment Agreements on November 5, 2026 with four executives, amending and superseding prior agreements. Base salaries were set at $400,000 each for Craig B. Greathouse (EVP, Chief Administrative Officer) and Michael R. Sumbs (EVP, CFO), $425,000 for Michael L. Gigorio (EVP, CIO and COO), and $416,000 for Joseph R. Rodriguez, whose title changed from Chief Risk Officer to EVP, Chief Legal Officer and Corporate Secretary. Severance terms were revised to 12 months base salary plus COBRA and pro-rated bonus for termination without cause, and 2.0x salary plus target bonus with up to 24 months COBRA in a change-in-control scenario, with payments subject to regulatory reduction and clawback provisions.
- · Joseph R. Rodriguez's title changed from Chief Risk Officer to EVP, Chief Legal Officer and Corporate Secretary
- · Severance on termination without cause (no change in control): 12 months base salary, COBRA cost for up to 12 months, and pro-rated annual bonus
- · Severance on termination without cause in connection with change of control: lump-sum 2.0x of annualized base salary plus target annual bonus, plus COBRA cost for up to 24 months
- · Payments are subject to reduction or modification to comply with banking laws and regulations and to MVB's compensation clawback policy
- · Restated Agreements filed as Exhibits 10.1, 10.2, 10.3 and 10.4; signed by CEO Larry F. Mazza on November 9, 2026
- · Executives remain eligible for the same compensation and benefits and material terms as prior agreements except as described
09-11-2026
Hims & Hers Health expanded its board from nine to ten directors and appointed Dr. Andrew Huberman, 51, effective November 4, 2026; the board determined he does not meet NYSE independence standards and he was not appointed to any committee. Alongside the board seat, subsidiary Hims, Inc. signed a two-year advisory agreement paying Huberman $3,500,000 annually in cash (plus up to $1,000,000/year for short-form ad videos) and a separate up-to-three-year podcast advertising deal with his co-owned Scicomm Media LLC at $5,000,000 annually, in which his approximate interest is $2,100,000 per year. His director compensation is a $50,000 annual cash retainer and a $250,000 annual equity award, prorated through the 2027 annual meeting.
- · Board size increased from nine to ten directors effective November 4, 2026
- · Dr. Huberman will serve until the 2027 annual meeting of stockholders
- · Board determined Huberman does not meet NYSE independence requirements
- · Advisory Agreement may be terminated early only by mutual agreement or for uncured material breach
- · Marketing Agreement may be terminated early by either party for convenience effective no earlier than November 5, 2027
- · Advisory and Marketing Agreements will be filed as exhibits to the Form 10-K for year ending December 31, 2026
- · Huberman will enter into the Company's standard form of indemnification agreement
- · No family relationships or other Item 404(a) transactions beyond the two agreements
09-11-2026
Fortune Brands Innovations elected Victor Grizzle, former 10-year CEO and current Executive Chair of Armstrong World Industries, as a Class I director effective January 1, 2027, through the 2027 annual meeting. The company also disclosed the retirements of longtime directors David Mackay (effective December 9, 2026) and Ann Fritz Hackett (effective following the 2027 annual meeting), both of whom joined the board in 2011 at the spin-off. The changes add building-products leadership experience while removing two 15-year board veterans, a mixed governance transition with no financial metrics disclosed.
- · Grizzle's election is effective January 1, 2027, with a term continuing until the 2027 annual meeting of shareholders
- · David Mackay retires December 9, 2026, after 15 years of service
- · Ann Fritz Hackett retires effective immediately following the 2027 annual meeting of shareholders
- · Both retiring directors joined the board in 2011 when Fortune Brands began trading as an independent company following a spin-off
- · Grizzle is also an independent director of Franklin Electric Co.
- · Grizzle previously held senior leadership roles at Valmont Industries and GE
- · No financial or operational performance figures were disclosed in this filing
09-11-2026
Pangaea Logistics Solutions Ltd. disclosed in an 8-K that Chairman Richard T. du Moulin notified the Board on November 3, 2026 of his decision to retire effective December 31, 2026. Mr. du Moulin has served as a director since the company's 2014 IPO, with his affiliation to the company spanning more than 25 years; Lead Independent Director and co-founder Claus Boggild praised his tenure. The filing contains no financial figures, no successor chair announcement, and no compensatory arrangements, leaving a leadership transition at the top of the Board unresolved as of the filing date.
- · Retirement effective date is December 31, 2026; notice given November 3, 2026 and reported November 9, 2026
- · No successor Chair or replacement director was named in the filing
- · No compensatory arrangements or severance terms were disclosed under Item 5.02
- · Company is Bermuda-incorporated, with principal executive offices at 109 Long Wharf, Newport, Rhode Island
- · Common stock trades on Nasdaq under ticker PANL
09-11-2026
UnitedHealth Group appointed Madeline S. Bell, former president and CEO of Children's Hospital of Philadelphia (CHOP), to its Board of Directors effective November 9, 2026. Bell spent four decades at CHOP, serving as COO from 2007 to 2015 and CEO from 2015 until her retirement last month. The filing contains no financial figures or period-over-period metrics; it is a governance/board composition update.
- · Bell started at CHOP as a pediatric staff nurse in 1983
- · Bell retired as CHOP CEO last month (October 2026)
- · Bell holds an M.S. in organizational dynamics from the University of Pennsylvania and a B.S. in nursing from Villanova University
- · Bell currently serves as a board director for Comcast
- · Bell previously chaired the Federal Reserve Bank of Philadelphia's Board of Directors
- · Bell is a fellow of The College of Physicians of Philadelphia and Honorary Consul of Spain
- · Filing is an 8-K under Item 5.02 (Director/Officer Departure/Election) with exhibit EX-99.1
09-11-2026
GeoVax Labs disclosed a major board and management shakeup: five directors resigned effective October 23, 2026, and Shahin Behroyan (age 39, Vancouver entrepreneur and CEO of iSpecimen since August 26, 2026) was appointed to the Board effective November 5, 2026 as an independent director. Effective November 8, 2026, Tyler O'Brien was named interim CEO and Chairman of the Board. The filing also references the prior termination of Mr. Dodd for 'Cause,' with risk disclosure that he may dispute the determination, potentially triggering severance of three times base salary plus target bonus and accelerated option vesting, alongside legal costs and reputational risk.
- · Five former directors resigned effective October 23, 2026; Behroyan was appointed by majority board vote to fill a vacancy
- · Behroyan has not been appointed to any Board committee and will receive standard non-employee director compensation
- · Behroyan is deemed independent under Nasdaq Listing Rule 5605(a)(2) and Rule 10A-3 of the Exchange Act
- · No family relationships or Item 404(a) related-party transactions disclosed for Behroyan
- · O'Brien will perform principal executive officer functions, including SOX 302/906 and Exchange Act 13a-14/15d-14 certifications
- · Risk factors flag potential Dodd litigation/arbitration, severance obligations, legal fees, negative publicity, and ability to identify and retain a permanent CEO
- · Forward-looking risks also include Nasdaq continued listing compliance, going-concern ability, and capital-raising needs
09-11-2026
Vestis Corporation filed an 8-K on November 9, 2026 disclosing an officer change under Item 5.02, with the appointment effective November 4, 2026. The filing states Mr. Tiejema will not receive any additional compensation from the Company in connection with the arrangement, and references prior disclosures incorporated by reference from the Company's September 28, 2026 Form 8-K. The filing was signed by André C. Bouchard, Executive Vice President, Chief Legal Officer, General Counsel and Secretary.
- · Officer change effective November 4, 2026
- · Mr. Tiejema will not receive any additional compensation from the Company in connection with the arrangement
- · Filing incorporates by reference information from the Company's Form 8-K filed with the SEC on September 28, 2026
- · 8-K signed on November 9, 2026 by André C. Bouchard
09-11-2026
KBR announced the future eight-member Board of Directors for Trinzic, the planned spin-off of its Mission Technology Solutions business, expected to launch January 4, 2027. Retired Lt. Gen. Wendy M. Masiello is expected to serve as Chair and CEO-designate Michael LaRouche as a director; the appointments remain subject to final KBR Board approval and customary conditions. Trinzic is expected to launch with more than $5 billion in annual revenue and 20,000 employees, while post-separation KBR will operate with 16,000 employees across more than 30 countries.
- · Trinzic is expected to launch on January 4, 2027, as an independent public company.
- · Board appointments and the separation remain subject to final approval by KBR's Board of Directors and other customary conditions.
- · Nchacha E. Etta and Wendy Masiello currently serve on KBR's board and plan to retire from it to transition to Trinzic's board.
- · Mark W. Sopp will retire from KBR and join the Trinzic board once the spin-off is complete.
- · Michael LaRouche joined the company in September and previously served as CEO of Serco North America and President of SAIC's National Security and Space Sector.
- · Gen. B. Chance Saltzman concluded his 34-year military career in November 2026 as the second Chief of Space Operations of the U.S. Space Force.
- · The Trinzic name is inspired by the word 'intrinsic'.
- · KBR describes itself as a capital-light lifecycle solutions company serving high-complexity industrial, energy and infrastructure markets.
09-11-2026
Upstart Holdings disclosed in an 8-K that Chief Accounting Officer (Principal Accounting Officer) Natalia Mirgorodskaya resigned effective November 30, 2026, to pursue another opportunity, with the company stating the departure is not due to any disagreement over operations, policies or practices. CFO Andrea Blankmeyer will serve as Interim Principal Accounting Officer during a search for a permanent replacement, with no change to her compensation. The filing contains no financial results or monetary figures.
- · Resignation notice given November 3, 2026; effective date November 30, 2026
- · Andrea Blankmeyer's compensation is not being adjusted for the interim appointment
- · No arrangements or understandings between Blankmeyer and any other person regarding the appointment
- · Item 5.02(c)(2) information on Blankmeyer incorporated by reference to the Proxy Statement filed April 16, 2026
- · 8-K signed by Scott Darling, Chief Legal Officer, dated November 9, 2026
- · Company is a Delaware corporation, Commission File Number 001-39797, IRS EIN 46-4332431, headquartered at 220 Park Road, Suite 500, Burlingame, CA 94010
09-11-2026
Energy Fuels Inc. appointed Mr. Jeffrey Olsen as a director and member of the Audit Committee, effective November 3, 2026. In connection with the appointment, Olsen received 2,078 restricted stock units at a grant price of $7.99 per common share, vesting in three installments through January 27, 2029. The filing notes no arrangements or understandings, no family relationships, and no related-party transactions requiring disclosure under Item 404(a).
- · Board appointment effective November 3, 2026, with 8-K filed November 9, 2026
- · Olsen will receive an annual retainer consistent with the non-employee director compensation program described in the definitive proxy statement filed April 17, 2026
- · RSU vesting schedule: 1,039 on January 27, 2027; 519 on January 27, 2028; 520 on January 27, 2029
- · Company incorporated in Ontario, Canada; common shares trade on NYSE American (UUUU) and TSX (EFR)
09-11-2026
NIKE appointed Dan McKenzie, 55, as Vice President, Chief Accounting Officer, Finance Operations & Transformation, and principal accounting officer effective November 9, 2026, following his retirement from the company in July 2026 after more than 19 years in finance leadership roles. Concurrently, CFO David Denton ceased serving as Interim Corporate Controller and principal accounting officer as of the same date, though he remains EVP and CFO. McKenzie's package includes a $500,000 base salary, a 50% target bonus, a $525,000 annual LTI target, and one-time equity awards including a $600,000 sign-on RSU grant.
- · McKenzie previously served as VP, CFO, Global Operations and Technology (August 2025–July 2026), VP, CFO, North America (July 2023–July 2025), and VP, CFO, EMEA (November 2019–June 2023)
- · No arrangements or understandings, family relationships, or Item 404(a) related-party transactions exist between McKenzie and the company
- · Under the noncompete agreement, if terminated without cause the company pays monthly one-twelfth of annual base salary for 12 months; if he voluntarily resigns, monthly one-twenty fourth of annual base salary
- · The company may unilaterally waive the noncompete covenant and cease corresponding payments
- · Offer letter dated November 4, 2026; appointment announced November 9, 2026
- · McKenzie holds a Bachelor of Science in Accounting from the University of Oregon
09-11-2026
AGNT, Inc. (formerly eXp World Holdings, ticker EXPI/AGNT) disclosed a Termination and Release Agreement with founder and Chairman Glenn Sanford, effective retroactively to October 8, 2026, the date his employment ended following the previously announced CEO transition. Sanford remains Chairman of the Board and retains revenue share eligibility at the highest FLQA tier for as long as he holds Vested Status, plus up to 12 months of COBRA reimbursement; however, the Release has not yet become effective, and contrary to prior guidance no consulting agreement was entered into. The agreement includes mutual releases (with carve-outs for fraud, securities-law claims, and pending derivative litigation), IP assignment to the Company, four-year confidentiality, mutual non-disparagement, and continued indemnification/D&O coverage for at least six years.
- · Separation Date of October 8, 2026 aligns with the prior 8-K announcing the CEO transition
- · Termination Agreement was signed November 9, 2026 but effective retroactively as of October 8, 2026
- · Sanford's revenue share is calculated at the highest FLQA tier without regard to FLQA qualification requirements, and survives termination/expiration of the agreement while Vested Status is retained
- · Revenue share entitlement continues to designated successors upon Sanford's death per the agent succession policy
- · No consulting agreement was entered into, reversing the prior 8-K's expectation of a Consulting Services Agreement
- · Company release of claims excludes fraud, willful misconduct, knowing violation of law, breach of duty of loyalty, federal/state securities claims, and claims in current or derivative lawsuits where Sanford is a defendant
- · Sanford assigns pre-separation work-product IP to the Company (not conditioned on the Release) and grants a perpetual royalty-free license to related materials, while retaining ownership of his name, image, likeness, voice, signature and biographical information
- · Disputes governed by Texas law with binding confidential arbitration in King County, Washington
- · Full Termination Agreement to be filed as an exhibit to the Form 10-K for fiscal year ending December 31, 2026
- · Sanford's director compensation and Board service are unaffected by the agreement
09-11-2026
Concentra executed a CEO succession effective November 1, 2026: Matthew DiCanio moved from President/CFO to President and CEO, William K. Newton transitioned from CEO to Executive Chairman, and Tanner Newton became EVP and CFO. New employment agreements set DiCanio's base salary at $785,000 with a 125% target bonus, K. Newton at $550,000 with an 85% target bonus, and T. Newton at $425,000 with a 75% target bonus. On November 3, 2026, the compensation committee granted restricted stock to named executives, including 164,894 shares to DiCanio and 138,812 to K. Newton, vesting equally over four years.
- · Severance for DiCanio: 24 months base salary continuation (30 months if termination within 3 months before to 12 months after a Change in Control), plus COBRA up to 18 months and pro rata equity vesting; full equity vesting on CIC-related termination
- · Severance for K. Newton: 24 months base salary continuation, COBRA up to 18 months, pro rata equity vesting; full equity vesting on CIC-related termination
- · Severance for T. Newton: 18 months base salary continuation (24 months on CIC-related termination), COBRA up to 18 months, pro rata equity vesting
- · K. Newton Agreement initial term runs through the 2027 annual meeting, auto-renewing one-year terms; T. Newton Agreement has a one-year initial term with automatic one-year renewals
- · K. Newton's CEO-to-Executive Chairman transition is not treated as a termination for his outstanding equity awards and does not constitute Good Reason
- · Restricted stock awards vest equally on each of the first four anniversaries of the November 3, 2026 grant date
- · Employment Agreements will be filed as exhibits to the Form 10-K for fiscal year ending December 31, 2026
- · Board will nominate DiCanio for election as a director at each applicable annual stockholders meeting while he serves as CEO
09-11-2026
Bain Capital Private Credit appointed Amrit Kanwal, 61, as an independent Class III trustee effective November 4, 2026, expanding the Board from eight to nine members. He was also named to the Audit, Nominating and Corporate Governance, and Compensation Committees, and concurrently joined the board of Bain Capital Specialty Finance, Inc. His term expires at the 2028 annual shareholder meeting; the filing discloses no financial terms, no related-party transactions, and no compensatory arrangements beyond standard independent trustee compensation.
- · Kanwal's Class III trustee term expires at the 2028 annual meeting of shareholders
- · Board determined Kanwal is independent under SEC independence standards
- · No arrangements or understandings between Kanwal and any other persons regarding his appointment
- · No family relationships between Kanwal and any trustee or executive officer
- · No transactions requiring disclosure under Item 404(a) of Regulation S-K
- · Kanwal will receive the standard compensation paid to the Company's Independent Trustees
- · Company is an emerging growth company and has elected not to use the extended transition period for new accounting standards
- · No securities are registered under Section 12(b); trading symbol listed as N/A
- · Kanwal previously served as EVP and CFO of MFS Investment Management and CFO of Putnam Investments
- · Kanwal concurrently appointed as independent director of Bain Capital Specialty Finance, Inc. effective November 4, 2026
09-11-2026
BCSF reported Q3 2026 net investment income of $27.7 million ($0.43/share, a 10.3% annualized NII yield on book value) and net income of $0.26/share (6.2% annualized return), with EPS improving from $0.22 in Q2 2026. However, NII declined from $28.6 million ($0.44/share) in Q2 2026, total investment income fell to $59.9 million from $62.3 million and from $67.2 million a year earlier, and NAV per share slipped to $16.49 from $16.65 at June 30, 2026 and $17.23 at December 31, 2025. The Board declared a $0.42 Q4 2026 dividend, while non-accruals held at 3.3% of the portfolio at amortized cost (2.2% at fair value) and net debt-to-equity eased to 1.18x from 1.22x.
- · Total investment income fell 10.9% YoY to $59.9M from $67.2M in Q3 2025
- · Net investment income declined YoY to $27.7M from $29.2M in Q3 2025
- · NAV per share declined 4.3% from $17.23 at Dec 31, 2025 to $16.49 at Sept 30, 2026
- · Q3 2026 net realized and unrealized losses were $11.0M
- · Gross fundings fell to $121.5M from $182.0M in Q2 2026; net investment activity was $(81.6)M vs $(95.2)M
- · Portfolio comprised of 215 companies across 30 industries; first lien loans 62.3% of fair value
- · Sumitomo Credit Facility commitment raised to $955.0M from $855.0M
- · Total principal debt outstanding $1,340.0M including $300.0M senior unsecured notes due October 2026
- · Q4 dividend payable December 29, 2026 to holders of record December 15, 2026
- · Earnings call scheduled November 10, 2026 at 10:00 a.m. ET
09-11-2026
I-ON Digital Corp. appointed Carson Knuth, age 40, to its Board of Directors and as President of the Company's Digital Asset Group on November 3, 2026, disclosed via 8-K on November 9, 2026. The role is explicitly non-executive, and Knuth has served as Senior Technical Advisory Consultant since May 2024. No financial terms, compensation, or equity arrangements were disclosed in the filing.
- · Appointment effective November 3, 2026; 8-K filed November 9, 2026
- · Knuth has been Managing Partner of Western Strategies since June 2022
- · Knuth has been Co-owner of Rogue Sports, a Las Vegas esports team, since April 2016
- · Knuth served as Senior Technical Advisory Consultant to I-ON Digital Corp. since May 2024
- · Knuth co-founded LEET (video gaming/bitcoin integration) and Rogue esports; both were later acquired by large multinational companies
- · Knuth has spoken at M.I.T., BYU, and UNLV, and toured Asia and the Middle East on cryptocurrency and DeFi topics
- · Company is not an emerging growth company; no securities registered under Section 12(b)
- · No compensation or compensatory arrangement details disclosed under Item 5.02
09-11-2026
Lisata Therapeutics held its 2026 Annual Meeting on November 9, 2026, with 75.64% of the 10,804,066 outstanding shares represented. Stockholders approved six of seven voted proposals, including election of Cynthia L. Flowers and Dr. Ted W. Love as Class I directors, ratification of Grant Thornton LLP as auditor, a reverse stock split authorization (1-for-5 to 1-for-15), the 2026 Equity Incentive Plan (44,764,472 share reserve), the 2026 ESPP (3,730,372 share reserve), and advisory approval of executive compensation. However, the critical Proposal No. 3 — approval of share issuance upon conversion of Series C Non-Voting Convertible Preferred Stock that would represent over 20% of outstanding shares and result in a change of control — was adjourned with no vote taken, and will be reconvened on November 30, 2026, pending Nasdaq listing application approval.
- · Proposal No. 3 (Series C conversion / change of control) was adjourned with no vote taken; reconvened meeting set for November 30, 2026 at 11:00 a.m. Eastern Time via live webcast
- · Record date for the Reconvened Meeting remains October 9, 2026
- · 2026 Plan reserve auto-increases 5% of outstanding shares each January 1 beginning 2027
- · 2026 ESPP reserve auto-increases each January 1 from 2027 through 2036 by the lesser of the Initial Reserve, 1% of outstanding shares, or a lesser amount
- · Board approved the 2026 Plan and 2026 ESPP on October 7, 2026, subject to stockholder approval
- · Proxy Statement filed on Schedule 14A on October 19, 2026
- · Say-on-pay received 975,321 votes against and 267,353 abstentions, indicating notable dissent
- · 2026 Equity Incentive Plan drew 1,552,345 votes against, the highest opposition among approved proposals
- · Directors elected to serve until the 2029 Annual Meeting of Stockholders
- · Exhibits 10.1 (2026 Plan) and 10.2 (2026 ESPP) filed with the 8-K
09-11-2026
SiriusXM announced that Anjali Sud, currently CEO of Tubi and a SiriusXM independent director since March 2025, will become CEO effective January 1, 2027, succeeding Jennifer Witz, who steps down after nearly 25 years at the company including almost six years as CEO and will serve in an advisory role through the end of 2027. The board framed the transition as building on momentum, citing a return to revenue growth and near-record free cash flow, though the filing itself discloses no specific financial figures and its risk factors continue to flag subscriber losses at SiriusXM and monthly active user declines at Pandora.
- · Sud's appointment is effective January 1, 2027; Witz remains an advisor until the end of 2027
- · Sud has been a SiriusXM independent director since March 2025 and will remain on the Board as CEO
- · Sud has led Tubi as CEO since 2023 and previously served as CEO of Vimeo, taking it public
- · Sud also serves on the boards of Dolby Laboratories and Change.org; holds a Wharton undergraduate degree and a Harvard MBA
- · Filing references the Form 10-Q for the period ended September 30, 2026 and the Form 10-K for the year ended December 31, 2025
- · Risk factors continue to cite SiriusXM subscriber losses and Pandora monthly active user declines
- · Witz credited with record-high customer satisfaction and record-low churn, plus building one of the nation's leading podcast networks
09-11-2026
LKQ Corporation announced that Salvatore A. "Sal" Abbate assumed the role of President and CEO and joined the Board of Directors effective November 9, 2026, ahead of his previously announced December 15, 2026 start date. His earlier arrival concludes the interim Office of the CEO led by Chairman John Mendel and Audit Committee Chair Sue Gove, which had overseen operations since October 23. The filing contains no financial results or performance metrics, so there is no period-over-period data to compare.
- · Abbate's start date moved up from the previously announced December 15, 2026 to November 9, 2026
- · Interim Office of the CEO had overseen operations since October 23
- · LKQ operates in North America, Europe and Taiwan
- · LKQ trades on Nasdaq under ticker LKQ
- · Investor contact phone: (312) 621-2793
09-11-2026
Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) appointed Jason Blessing, age 55, as a new independent director effective November 6, 2026, with service on the Audit Committee and Nominating and Corporate Governance Committee; the Board determined he is independent under Nasdaq listing standards. Blessing brings more than 30 years of leadership experience, including as President and CEO of Model N, Inc. from May 2018 to September 2024 (leading its cloud transition and 2024 sale to Vista Equity Partners) and as President and CEO of Plex Systems from January 2013 to December 2017. The filing contains no financial results or period-over-period metrics, so no positive, negative, or flat performance data is available to assess.
- · Blessing's appointment was effective November 6, 2026, three days before the November 9, 2026 filing date
- · Blessing served on Model N's Board of Directors from May 2018 to August 2026
- · Blessing currently serves as Executive Chair of Mosai and as a director of eClinical Solutions and Parsec Automation, and as an advisor to the CEO of AptEdge
- · Blessing earned a Bachelor's Degree from the University of Michigan
- · Evolv Express® and Evolv eXpedite™ hold DHS SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT)
- · Investor contact: Brian Norris, SVP of Finance and Investor Relations, +1.781.374.8082
09-11-2026
SM Energy appointed George Green as Senior Vice President – Chief Legal Officer and Corporate Secretary effective November 9, 2026. Concurrently, James Lebeck, previously EVP – Chief Corporate Development Officer, General Counsel and Corporate Secretary, will continue as EVP – Chief Corporate Development Officer, relinquishing the legal and secretary roles. The filing contains no financial figures or period-over-period metrics.
- · George Green joined SM Energy from PerkinElmer, where he served as General Counsel since June 2023
- · Green previously spent nine years at DCP Midstream, including Group Vice President and General Counsel from 2021 to 2023
- · Before DCP Midstream, Green practiced law at Arnold & Porter in Denver, Colorado
- · James Lebeck retains the EVP – Chief Corporate Development Officer title but no longer serves as General Counsel or Corporate Secretary
- · Filing signed by Alan D. Bennett, Vice President – Controller (Principal Accounting Officer)
- · Common stock trades on NYSE under symbol SM, $0.01 par value
09-11-2026
Century Communities (NYSE: CCS) announced the promotion of Jim Francescon to President effective January 1, 2027, as part of a two-year long-term succession plan. Current CEO Rob Francescon will retain the CEO role while Dale Francescon continues as Executive Chairman, so the CEO position is unchanged. The filing contains no financial results or monetary figures; it is a leadership/succession disclosure with no period-over-period metrics to compare.
- · Jim Francescon joined Century in 2019 and most recently served as Executive Vice President, Corporate Operations
- · Francescon previously was President of Century Living (multifamily platform) and before that Corporate Vice President
- · Prior to Century, he worked in private equity at GoldPoint Partners (New York Life Investments subsidiary) and investment banking at J.P. Morgan Securities LLC
- · He led recent acquisitions of HistoryMaker Homes, Anglia Homes, and Landmark Homes of Tennessee, expanding presence in Dallas-Fort Worth, Houston, and Nashville respectively
- · He holds a BS in Business Administration (Finance and Real Estate) and an MS in Finance from the University of Denver
- · He serves as a Trustee of the University of Denver, Children's Hospital Colorado Foundation, and ACE Scholarships Colorado
- · The succession plan has been planned and executed over the past two years per Executive Chairman Dale Francescon
- · Forward-looking statements flag risks including leadership changes, interest rates, inflation, tariffs, and integration of the HistoryMaker Homes acquisition
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 45 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Corporate Board Director Changes SEC Filings
November 05, 2026
US Corporate Board Director Changes SEC Filings — November 05, 2026
November 04, 2026
US Corporate Board Director Changes SEC Filings — November 04, 2026
November 03, 2026
US Corporate Board Director Changes SEC Filings — November 03, 2026
November 02, 2026
US Corporate Board Director Changes SEC Filings — November 02, 2026
🇺🇸 More from United States
View all →November 10, 2026
US Pre-Market SEC Filings Roundup — November 10, 2026
US Pre-Market SEC Filings Roundup
November 10, 2026
US Merger & Acquisition SEC Filings — November 10, 2026
US Merger & Acquisition SEC Filings
November 10, 2026
USA Insider Trading Pulse — November 10, 2026
USA Insider Trading Pulse
November 09, 2026
US Pre-Market SEC Filings Roundup — November 09, 2026
US Pre-Market SEC Filings Roundup